BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 23789583)

  • 1. Inappropriate use of combined hormonal contraceptives for birth control among women of reproductive age in the United States.
    Yu J; Hu XH
    J Womens Health (Larchmt); 2013 Jul; 22(7):595-603. PubMed ID: 23789583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined hormonal contraception use in reproductive-age women with contraindications to estrogen use.
    Lauring JR; Lehman EB; Deimling TA; Legro RS; Chuang CH
    Am J Obstet Gynecol; 2016 Sep; 215(3):330.e1-7. PubMed ID: 27059507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of hormonal contraceptives among women with migraine: A systematic review.
    Tepper NK; Whiteman MK; Zapata LB; Marchbanks PA; Curtis KM
    Contraception; 2016 Dec; 94(6):630-640. PubMed ID: 27153744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2016: Revised Recommendations for the Use of Hormonal Contraception Among Women at High Risk for HIV Infection.
    Tepper NK; Krashin JW; Curtis KM; Cox S; Whiteman MK
    MMWR Morb Mortal Wkly Rep; 2017 Sep; 66(37):990-994. PubMed ID: 28934178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of combined hormonal contraceptives among women with migraines and risk of ischemic stroke.
    Champaloux SW; Tepper NK; Monsour M; Curtis KM; Whiteman MK; Marchbanks PA; Jamieson DJ
    Am J Obstet Gynecol; 2017 May; 216(5):489.e1-489.e7. PubMed ID: 28034652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2010: revised recommendations for the use of hormonal contraception among women at high risk for HIV infection or infected with HIV.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Jun; 61(24):449-52. PubMed ID: 22717514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.
    Johnson NB; Hayes LD; Brown K; Hoo EC; Ethier KA;
    MMWR Suppl; 2014 Oct; 63(4):3-27. PubMed ID: 25356673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unsafe use of combined hormonal contraceptives poses health risks for women with medical conditions.
    Bond S
    J Midwifery Womens Health; 2014; 59(1):103-4. PubMed ID: 24588885
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
    Lancet; 1997 Apr; 349(9060):1202-9. PubMed ID: 9130941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discontinuation of modern hormonal contraceptives: an Italian survey.
    Fruzzetti F; Perini D; Fornaciari L; Russo M; Bucci F; Gadducci A
    Eur J Contracept Reprod Health Care; 2016 Dec; 21(6):449-454. PubMed ID: 27715345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular disease and steroid hormone contraception. Report of a WHO Scientific Group.
    World Health Organ Tech Rep Ser; 1998; 877():i-vii, 1-89. PubMed ID: 9615606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of UK Medical Eligibility Criteria implementation on prescribing of combined hormonal contraceptives.
    Briggs PE; Praet CA; Humphreys SC; Zhao C
    J Fam Plann Reprod Health Care; 2013 Jul; 39(3):190-6. PubMed ID: 23299629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Broad counseling for adolescents about combined hormonal contraceptive methods: the choice study.
    Merki-Feld GS; Gruber IM
    J Adolesc Health; 2014 Apr; 54(4):404-9. PubMed ID: 23932259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC).
    Sacco S; Merki-Feld GS; Ægidius KL; Bitzer J; Canonico M; Kurth T; Lampl C; Lidegaard Ø; Anne MacGregor E; MaassenVanDenBrink A; Mitsikostas DD; Nappi RE; Ntaios G; Sandset PM; Martelletti P;
    J Headache Pain; 2017 Oct; 18(1):108. PubMed ID: 29086160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contraception in adolescents with anorexia nervosa. Is there evidence for a negative impact of combined hormonal contraceptives on bone mineral density and the course of the disease?
    Merki-Feld GS; Bitzer J
    Eur J Contracept Reprod Health Care; 2020 Jun; 25(3):213-220. PubMed ID: 32336145
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of combined hormonal contraceptives among women with systemic lupus erythematosus with and without medical contraindications to oestrogen.
    Mendel A; Bernatsky S; Pineau CA; St-Pierre Y; Hanly JG; Urowitz MB; Clarke AE; Romero-Diaz J; Gordon C; Bae SC; Wallace DJ; Merrill JT; Buyon J; Isenberg DA; Rahman A; Ginzler EM; Petri M; Dooley MA; Fortin P; Gladman DD; Steinsson K; Ramsey-Goldman R; Khamashta MA; Aranow C; Mackay M; Alarcón G; Manzi S; Nived O; Jönsen A; Zoma AA; van Vollenhoven RF; Ramos-Casals M; Ruiz-Irastorza G; Lim S; Kalunian KC; Inanc M; Kamen DL; Peschken CA; Jacobsen S; Askanase A; Sanchez-Guerrero J; Bruce IN; Costedoat-Chalumeau N; Vinet E
    Rheumatology (Oxford); 2019 Jul; 58(7):1259-1267. PubMed ID: 30753683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal contraception.
    Baird DT; Glasier AF
    N Engl J Med; 1993 May; 328(21):1543-9. PubMed ID: 8479492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined hormonal contraceptives use among women with contraindications according to the WHO criteria: A systematic review.
    Houvèssou GM; Farías-Antúnez S; da Silveira MF
    Sex Reprod Healthc; 2021 Feb; 27():100587. PubMed ID: 33545506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in prescription rates and odds ratios of antidepressant drugs in relation to individual hormonal contraceptives: a nationwide population-based study with age-specific analyses.
    Lindberg M; Foldemo A; Josefsson A; Wiréhn AB
    Eur J Contracept Reprod Health Care; 2012 Apr; 17(2):106-18. PubMed ID: 22385398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of combined hormonal contraception on health and wellbeing: women's knowledge in northern Italy.
    Nappi RE; Pellegrinelli A; Campolo F; Lanzo G; Santamaria V; Suragna A; Spinillo A; Benedetto C
    Eur J Contracept Reprod Health Care; 2015 Feb; 20(1):36-46. PubMed ID: 25317952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.